NASHUA, N.H. and SAN RAFAEL, Calif., June 6 /PRNewswire-FirstCall/ -- iCAD(R), Inc. , an industry-leading provider of Computer-Aided Detection (CAD) solutions for the early identification of cancer, today announced that Viewport Medical Systems has signed an agreement to resell it's ClickCAD(TM) Fee-For-Procedure solution. The partnership will provide smaller institutions access to leading CAD technology typically only available to larger practices and hospitals.
"CAD technology has evolved from the early adopters of two years ago to the mainstream medical practice of today because of proven clinical efficacy. Radiologists now view CAD as a necessary tool to aid in the early detection of breast cancer," said Ron Paul, Managing Partner of Viewport Medical Systems. "Through our partnership with iCAD we are able to use advanced Internet marketing techniques to target smaller practices with limited resources. With ClickCAD, every mammography screening facility is now able to cost-effectively provide patients with the peace of mind that comes from using an industry- leading resource in cancer diagnosis."
The ClickCAD fee-per-procedure program works in conjunction with the iCAD Second Look(R) 200 system -- the market's only CAD system targeted to clinics and practices handling under 20 mammography screenings per day. iCAD's Second Look systems are designed to assist radiologists in the early detection of breast cancer during a mammography exam. With pricing starting at $5,500 and a cost as low as $8 per case, ClickCAD makes CAD more affordable and accessible to a greater number of doctors and patients. By purchasing a pre-paid procedure authorization key that allows the processing of up to 500 cases, there are no capital or long-term contract requirements.
"Our ultimate goal is to help doctors more accurately diagnose breast cancer," said W. Scott Parr, president and CEO of iCAD, Inc. "By engaging with Viewport Medical in a dedicated Internet marketing effort, we aim to make CAD technology more accessible to practices that don't have the financial resources of a large scale institution."
About Viewport Medical Systems
Viewport Medical Systems (VMS) division of AMC, LLC (http://www.ViewportMedical.com) is a San Francisco-based operation with regional sales managed by licensed Area Partners in local markets nationwide. Products offerings are selected and qualified by the Viewport Medical product management task force for Internet marketing. The ClickCAD pay-for-procedure program from iCAD represents an ideal combination of value and performance technology which can be target marketed to an established audience of medical professionals.
The management team of VMS has spent the last 35 years building companies. Area Partners are selected for their particular experience in the areas of Distribution Channel Management and Internet Marketing. VMS managers have built sales and marketing teams which have sold over $1 Billion in products worldwide. For more information, call +1 877 250 9403.
About iCAD, Inc.
iCAD, Inc. is an industry-leading provider of Computer-Aided Detection (CAD) solutions that enable healthcare professionals to identify cancer and other life-threatening conditions earlier by making medical services more effective, more accessible and more affordable for patients worldwide. Recipient of Frost & Sullivan's Growth Strategy Leadership award and repeatedly recognized as offering "The Winning Combination" of Price and Performance by MD Buyline, iCAD offers a comprehensive range of high- performance, upgradeable CAD systems for the high, mid and low volume mammography markets. As the most frequently selected CAD solution for film- based and digital breast screening, iCAD is entrusted with the task of early cancer detection by almost one thousand women's healthcare centers worldwide. For more information, call +1 877 iCADnow or visit http://www.icadmed.com.
"Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995:
Certain statements contained in this News Release constitute "forward- looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve a number of known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Such factors include, but are not limited to, the risks of uncertainty of patent protection, the impact of supply and manufacturing constraints or difficulties, product market acceptance, possible technological obsolescence, increased competition, customer concentration and other risks detailed in the Company's other filings with the Securities and Exchange Commission. The words "believe", "demonstrate", "intend", "expect", "estimate", "anticipate", "likely", and similar expressions identify forward- looking statements. Readers are cautioned not to place undue reliance on those forward-looking statements, which speak only as of the date the statement was made. The Company is under no obligation to provide any updates to any information contained in this release.
iCAD and Second Look are registered trademarks and ClickCAD is a trademark of iCAD, Inc.
For iCAD investor relations, contact Kevin McGrath of Cameron Associates at +1 212 245 4577 or via email at firstname.lastname@example.org.
For all other inquires, contact Monica Pandolfi of SHIFT Communications at +1 617 681 1235 or via email at email@example.com.